Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Elevated mortality seen in Merkel cell patients from rural areas
“There is a need for us to further interrogate what the causes are for this disparity in care between rural and urban centers,” Dr. Bryan T....
News
How does atopic dermatitis present in skin of color?
Morphological variants common in skin of color include the follicular variant or micropapular variant of AD.
News
Abrocitinib efficacy dose-dependent, similar across AD age groups
“We know that responses to, and adverse events associated with, systemic therapies may vary among patients of different ages.”
News
CRP elevated in adults with AD and sleep disturbance
“There is a consequence of not treating patients with atopic dermatitis, especially those patients with sleep disturbance.”
News
Filler complications involving vascular necrosis, vision changes on the rise
The three most common injection sites involving necrosis and vision changes were the cheek, the nose, and the nasolabial fold.
News
Review finds microneedling an effective add-on to topical melasma therapies
Twelve studies involving 459 patients from seven countries were included in the final analysis.
News
Expert shares top five atopic dermatitis–related questions he fields
Counseling about systemic therapy includes shared decision-making, Dr. Lawrence F. Eichenfield says.
News
Two questions can help establish a diagnosis of hidradenitis suppurativa
There is no perfect outcome measure yet, but progress is being made.
News
Certain opioids hold promise for treating itch
Difelikefalin is the first FDA-approved treatment for uremic pruritus associated with dialysis.
News
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
News
Rosacea is in the eye of the beholder, expert says
As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin.
News
Topical options for acne patients continue to expand
In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and...
News
Cannabinoids being studied for a variety of dermatologic conditions
Recent research shows that the endocannabinoid system is involved in modulation of the CNS and in immune function, particularly skin homeostasis...
News
What are the legal risks of practicing laser cutaneous surgery?
“The best way to avoid complications is to trust your eyes – not the laser,” Dr. Mathew M. Avram said.
News
Expert shares eye protection tips for cutaneous laser surgery
Only use eyewear designed for the specific laser wavelength you are using and check the optical density yourself prior to firing the laser, Dr....